↓ Skip to main content

Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes

Overview of attention for article published in BMC Endocrine Disorders, May 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
Published in
BMC Endocrine Disorders, May 2022
DOI 10.1186/s12902-022-01033-3
Pubmed ID
Authors

Fizalah Kawoosa, Zafar A. Shah, Shariq R. Masoodi, Asif Amin, Roohi Rasool, Khalid M. Fazili, Abid Hamid Dar, Asif Lone, Samir ul Bashir

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 3 14%
Student > Ph. D. Student 2 9%
Unspecified 1 5%
Student > Doctoral Student 1 5%
Student > Bachelor 1 5%
Other 3 14%
Unknown 11 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Agricultural and Biological Sciences 2 9%
Unspecified 1 5%
Medicine and Dentistry 1 5%
Other 2 9%
Unknown 12 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2022.
All research outputs
#14,227,059
of 23,576,969 outputs
Outputs from BMC Endocrine Disorders
#344
of 799 outputs
Outputs of similar age
#197,546
of 441,850 outputs
Outputs of similar age from BMC Endocrine Disorders
#14
of 39 outputs
Altmetric has tracked 23,576,969 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 799 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,850 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.